In cancers, such as MM, where tumour VDR enhances anti‐tumour immunity, loss of tumour VDR signalling might be expected to result in opposition of the elimination phase, tipping the equilibrium phase in favour of tumour progression and enhancement of the escape phase by the direct action of vitamin D3 on immunocytes. This evidence concerns the gene VDR and cancer.